Intravesical Bacillus Calmette is used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
In the last several years, Global market of Intravesical Bacillus Calmette developed rapidly, with an average growth rate of 5.33%. In 2018, after a huge decrease and recovery, Global revenue of Intravesical Bacillus Calmette is about 198 M USD.
Since 2017, Sanofi start to shut down its production facility, which caused a large short in the market. On the other hand, other manufacturers like Merck are expanding their capacity to fulfill the market demand.
North America region is the largest consumption of Intravesical Bacillus Calmette, with a sales revenue market share nearly 47.7% in 2018. Europe is the second largest consumer of Intravesical Bacillus Calmette, enjoying sales revenue market share about 35.5% in 2016.
According to this study, over the next five years the Intravesical Bacillus Calmette market will register a 8.4% CAGR in terms of revenue, the global market size will reach US$ 330 million by 2024, from US$ 220 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravesical Bacillus Calmette business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravesical Bacillus Calmette market by product type, application, key manufacturers and key regions and countries.
This study considers the Intravesical Bacillus Calmette value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
40mg/Vial
50mg/Vial
60mg/Vial
80mg/Vial
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Japan BCG Laboratory
China National Biotec
Serum Institute of India
GSBPL
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Intravesical Bacillus Calmette consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Intravesical Bacillus Calmette market by identifying its various subsegments.
Focuses on the key global Intravesical Bacillus Calmette manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravesical Bacillus Calmette with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Intravesical Bacillus Calmette submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
